Literature DB >> 19058026

Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences.

P Ravi Shankar1, Baburam Humagain, R M Piryani, Nisha Jha, Bidur Osti.   

Abstract

Drug and Therapeutics Committees (DTCs) serve as a forum to bring together various stakeholders to improve drug use. DTCs are a key intervention to promote rational use of medicines. DTCs are however, functioning in only a limited number of hospitals in Nepal. A Medicine and Therapeutics Committee (MTC) was started at KIST Medical College, a new medical school in Lalitpur district, Nepal to promote the rational use of medicines in February 2008. The MTC has members from various departments and the full support of the administration. The MTC has been involved in preparing the hospital medicine list and limiting the number of brands available in the pharmacy. Measures to regulate pharmaceutical promotion have been undertaken. Pharmacovigilance and medication counseling activities have been started. Educational programs for various levels of staff are regularly carried out and drug use in the hospital is periodically monitored. Initial experiences regarding MTC functioning is positive.

Mesh:

Year:  2008        PMID: 19058026     DOI: 10.1007/s11096-008-9263-y

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  6 in total

1.  Ten recommendations to improve use of medicines in developing countries.

Authors:  R Laing; H Hogerzeil; D Ross-Degnan
Journal:  Health Policy Plan       Date:  2001-03       Impact factor: 3.344

2.  Contribution of the regional drug information center towards drug safety.

Authors:  S Palaian; P Mishra; P R Shankar; D Bista; B Purwar
Journal:  JNMA J Nepal Med Assoc       Date:  2006 Jan-Mar       Impact factor: 0.406

3.  Role of drug and therapeutics committee towards drug safety--experiences from western Nepal.

Authors:  S Palaian; P Mishra
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2005 Jan-Mar

4.  Structure and activities of hospital drug committees in Germany.

Authors:  P A Thürmann; S Harder; A Steioff
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

5.  Drug and Therapeutics Committees in Australia: expected and actual performance.

Authors:  L M Weekes; C Brooks
Journal:  Br J Clin Pharmacol       Date:  1996-11       Impact factor: 4.335

6.  Developing the role of the drug and therapeutics committees: perceptions of chairs.

Authors:  Ingeborg K Björkman; Ingrid K Schmidt; Inger Holmström; Cecilia B Bernsten
Journal:  Int J Health Care Qual Assur       Date:  2007
  6 in total
  3 in total

1.  Student feedback about The Skeptic Doctor, a module on pharmaceutical promotion.

Authors:  P Ravi Shankar; Kundan K Singh; Rano M Piryani
Journal:  J Educ Eval Health Prof       Date:  2011-11-30

2.  Adherence and non-adherence to treatments: focus on pharmacy practice in Nepal.

Authors:  Suresh Bastakoti; Saval Khanal; Bibek Dahal; Nirmala Tilija Pun
Journal:  J Clin Diagn Res       Date:  2013-04-01

3.  Starting a pharmacovigilance program within a teaching hospital: Challenges and experiences from Lalitpur, Nepal.

Authors:  Nisha Jha; Omi Bajracharya; Rojeena Shrestha; Harish Singh Thapa; Pathiyil Ravi Shankar
Journal:  South Med Rev       Date:  2009-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.